Moneycontrol PRO
you are here: HomeNewsOrchid pharma
orchid pharma
Jump to
38 Results Found
  • Orchid Pharma shares hit 10% lower circuit on stake sale by a promoter Jun 24, 2021 12:50 PM IST

    Orchid Pharma shares hit 10% lower circuit on stake sale by a promoter

    Dhanuka Laboratories will sell 8.04 percent of the total share of the company on June 24 and June 25 via an offer for sale.

  • Orchid Pharma Consolidated December 2020 Net Sales at Rs 102.78 crore, down 20.61% Y-o-Y Feb 10, 2021 01:33 PM IST

    Orchid Pharma Consolidated December 2020 Net Sales at Rs 102.78 crore, down 20.61% Y-o-Y

  • Orchid Pharma Standalone December 2020 Net Sales at Rs 102.63 crore, down 20.18% Y-o-Y Feb 10, 2021 01:33 PM IST

    Orchid Pharma Standalone December 2020 Net Sales at Rs 102.63 crore, down 20.18% Y-o-Y

  • Orchid Pharma Standalone March 2020 Net Sales at Rs 110.11 crore, down 32.06% Y-o-Y Jul 01, 2020 10:22 AM IST

    Orchid Pharma Standalone March 2020 Net Sales at Rs 110.11 crore, down 32.06% Y-o-Y

  • Orchid Pharma Consolidated March 2020 Net Sales at Rs 111.52 crore, down 81.41% Y-o-Y Jul 01, 2020 10:13 AM IST

    Orchid Pharma Consolidated March 2020 Net Sales at Rs 111.52 crore, down 81.41% Y-o-Y

  • NCLAT sets aside NCLT order approving Dhanuka's bid for Orchid Pharma Nov 18, 2019 08:44 PM IST

    NCLAT sets aside NCLT order approving Dhanuka's bid for Orchid Pharma

    The appellate tribunal observed that the approved resolution value, which stood at Rs 1,146.04 crore, proposed by Dhanuka Laboratories was lower than the liquidation value of Rs 1,309 crore of the company.

  • Orchid Pharma Standalone June 2019 Net Sales at Rs 135.77 crore, up 3.92% Y-o-Y Aug 13, 2019 02:55 PM IST

    Orchid Pharma Standalone June 2019 Net Sales at Rs 135.77 crore, up 3.92% Y-o-Y

  • Orchid Pharma Consolidated June 2019 Net Sales at Rs 135.42 crore, up 0% Y-o-Y Aug 13, 2019 01:25 PM IST

    Orchid Pharma Consolidated June 2019 Net Sales at Rs 135.42 crore, up 0% Y-o-Y

  • Orchid Pharma Standalone December 2018 Net Sales at Rs 148.45 crore, up 2.92% Y-o-Y Feb 13, 2019 02:02 PM IST

    Orchid Pharma Standalone December 2018 Net Sales at Rs 148.45 crore, up 2.92% Y-o-Y

  • Orchid Pharma rallies 5% on establishment inspection report from USFDA for Chennai plant Jan 08, 2018 03:10 PM IST

    Orchid Pharma rallies 5% on establishment inspection report from USFDA for Chennai plant

    The pharma company informed exchanges that it has received the establishment inspection report from the US Food and Drug Administration on successful inspection closure for Chennai plant.

  • Orchid Pharma gets USFDA nod for schizophrenia drug Dec 13, 2017 03:32 PM IST

    Orchid Pharma gets USFDA nod for schizophrenia drug

    In a filing to BSE, the company said it "has received ANDA (abbreviated new drug application) approval from USFDA (United States Food and Drug Administration) for Aripiprazole Orally-Disintegrating tablets USP, 10 mg and 15 mg."

  • Orchid Pharma gets EIR from USFDA for its Alathur facility Sep 21, 2017 03:33 PM IST

    Orchid Pharma gets EIR from USFDA for its Alathur facility

    The company has received EIR from the United States Food and Drug Administration (USFDA) based on the successful inspection of the active pharmaceutical ingredients (API) manufacturing facility at Alathur, Orchid Pharma said in a filing to BSE.

  • Orchid Pharma settles case with Sebi, pays Rs 5.25 lakh Jul 26, 2017 08:41 AM IST

    Orchid Pharma settles case with Sebi, pays Rs 5.25 lakh

    In an order dated July 24, the Securities and Exchange Board of India (Sebi) settled the "possible proceedings" against Orchid Pharma related to alleged non-compliances by the firm of Sebi's ICDR (Issue of Capital and Disclosure Requirements) Regulations.

  • Buy Reliance Infra, OBC, Reliance Capital: Ashwani Gujral Apr 18, 2017 02:56 PM IST

    Buy Reliance Infra, OBC, Reliance Capital: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Reliance Infra, OBC and Reliance Capital.

  • Orchid Pharma soars 14% on establishment inspection report for Tamil Nadu unit Apr 18, 2017 01:02 PM IST

    Orchid Pharma soars 14% on establishment inspection report for Tamil Nadu unit

    Orchid Pharma received the establishment inspection report from the US Food & Drug Administration.

  • Sell Orchid Pharma on rally, says Vijay Chopra Apr 07, 2017 03:46 PM IST

    Sell Orchid Pharma on rally, says Vijay Chopra

    Vijay Chopra of enochventures.com advises selling Orchid Pharma.

  • Exit Orchid Pharma, says Prakash Gaba Apr 07, 2017 03:36 PM IST

    Exit Orchid Pharma, says Prakash Gaba

    According to Prakash Gaba of prakashgaba.com, one may exit Orchid Pharma.

  • Exit Orchid Pharma; pick Lupin, Sun Pharma: Avinash Gorakshakar Feb 20, 2017 03:26 PM IST

    Exit Orchid Pharma; pick Lupin, Sun Pharma: Avinash Gorakshakar

    Avinash Gorakshakar, Market Expert advises exiting Orchid Pharma and one can prefer Lupin and Sun Pharmaceutical Industries.

  • Exit Orchid Pharma closer to Rs 36: Prakash Gaba Feb 20, 2017 03:25 PM IST

    Exit Orchid Pharma closer to Rs 36: Prakash Gaba

    According to Prakash Gaba of prakashgaba.com, one may exit Orchid Pharma closer to Rs 36.

  • Stocks in news: Infosys, Axis, Tata Steel, Bharti, Quess, Titan Feb 08, 2017 08:00 AM IST

    Stocks in news: Infosys, Axis, Tata Steel, Bharti, Quess, Titan

    Infosys | Idea Cellular | Axis Bank | Tata Steel | Bharti Airtel | Bharat Forge | Hero Motocorp | Godawari Power | Jubilant Life Sciences | NHPC | Quess Corp | Titan Company and Jindal Stainless are stocks, which are in the news today.

  • Orchid Pharma Q3 net loss narrows to Rs 60.97 cr Feb 07, 2017 04:28 PM IST

    Orchid Pharma Q3 net loss narrows to Rs 60.97 cr

    The company had posted a net loss of Rs 94.02 crore in the year-ago period, Orchid Pharma said in a BSE filing.

  • Sell Orchid Pharma, says Prakash Gaba Nov 11, 2016 04:13 PM IST

    Sell Orchid Pharma, says Prakash Gaba

    According to Prakash Gaba of prakashgaba.com, one may sell Orchid Pharma.

  • Stocks in news: Sun Pharma, Tata Steel, Cipla, Parag Milk, UCO Nov 10, 2016 08:00 AM IST

    Stocks in news: Sun Pharma, Tata Steel, Cipla, Parag Milk, UCO

    Sun Pharma | Tata Steel | Cipla | Emkay Global | FDC | Bosch | Dhampur Sugar | Parag Milk | Narayana Hrudayalaya | IG Petro | Snowman Logistics | Jamna Auto | Caplin Point | Power Grid | Ramco Systems | UCO Bank | TBZ | Apollo Tyres and Tata Global are stocks, which are in the news today.

  • Stocks in news: Sun Pharma, Hindalco, Coal India, Tech Mahindra May 30, 2016 08:01 AM IST

    Stocks in news: Sun Pharma, Hindalco, Coal India, Tech Mahindra

    Sun Pharma | Tata Motors | M&M | Hindalco Industries | Coal India | Tech Mahindra | Sun TV Network | Religare Enterprises | Suzlon Energy | Maruti Suzuki and Diamond Power are stocks, which are in the news today.

  • Bull's Eye: Buy Voltas, MCX India, Biocon; sell Hexaware Apr 21, 2016 08:00 AM IST

    Bull's Eye: Buy Voltas, MCX India, Biocon; sell Hexaware

    Manish Sharma of derivativetradingresearch is of the view that one may buy Voltas with a target of Rs 310.

Sections
ISO 27001 - BSI Assurance Mark